Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term ...

Washington University School of Medicine researchers presented a study linking obesity to an increase in the progression ...

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral ...

Paul Edison, MD, PhD, of Imperial College London, who wasn't involved with the studies, called the findings "an undeniable ...

Alzheimer's disease often begins many years before memory problems appear. During that silent phase, toxic changes slowly ...

Results showed that people with obesity had blood biomarkers for Alzheimer’s that rose more rapidly, including: Tau proteins, ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

Alzheimer’s disease affects millions of people worldwide, robbing individuals of their memory, cognitive abilities and independence. While researchers continue searching for medical breakthroughs, one ...

It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...

B. Joy Snider's clinic focuses on early detection of memory issues, using biomarkers for precise Alzheimer's diagnosis and ...

A new study suggests the shingles vaccine may lower the likelihood of developing dementia as well as slow its progression in ...

A recent study revealed that obesity may accelerate the progression of Alzheimer’s disease.Scientists discovered that blood ...